跳至主要内容
临床试验/NCT05629156
NCT05629156已完成不适用

Injury and Illness Surveillance At the FIFA World Cup Qatar 2022TM

Federation Internationale de Football Association1 个研究点 分布在 1 个国家目标入组 705 人开始时间: 2022年11月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
705
试验地点
1
主要终点
Incidence and burden of Time-loss injuries

研究概览

简要总结

The project aims to provide an overview of injury and illnesses during the FIFA World Cup Qatar 2022. All teams are invited to participate and record details on time-loss injury and illness occurrence and training and match exposure during the tournament. In order to assess the severity of injuries (based on the length of time a player is unable to play for), all injuries are to be monitored until they are fully rehabilitated, even if this is after the end of the tournament. This information will be recorded by the team physicians and provided on daily report forms to the research team. Data will be encrypted before analysis and only anonymized data will be published. Descriptive statistics are used to provide an overview of the participant demographics and injury and illness occurrence. Injury incidence is calculated as number of injuries per 1000 hours of exposure, and injury burden is calculated as time-loss days per 1000 hours of exposure. Injury incidence and burden will be reported for training and match injuries separately. Illness incidence is calculated per 365 exposure days.

详细描述

Background Injury rates in football are closely associated with team performance. Teams are more likely to lose matches in which they have suffered injuries, and teams with fewer injuries have significantly better results both in international tournaments and in national leagues. Injuries can have both high short- and long-term consequences for an individual player's health and career. Illness rates in professional football is lower than injury rates, but it is unclear whether illness rates are higher in international tournaments, which often include travel, exposure to different environments, high match significance, and match congestion.

Injury surveillance is a cornerstone in the development of injury prevention programs. Injury and illness prevention strategies are continuously being developed and improved, and it is therefore important with ongoing surveillance. Additionally, there has been scientific advances in methodology, which can ensure more detailed and accurate information.

Objectives The primary objective is to provide an overview of the incidence and characteristics of time-loss injuries and illnesses during the FIFA World Cup Qatar 2022.

The primary variables of interest are time-loss injuries and time-loss illnesses.

  • Time-loss is defined as inability of a player to complete the current or future training session or match.
  • Injury is defined as tissue damage or other derangement of normal physical function resulting from rapid or repetitive transfer of kinetic energy.
  • Illness is defined as a health-related complaint or disorder experienced by an athlete, not considered as an injury.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Male
接受健康志愿者

入选标准

  • All participating football players at the FIFA World Cup Qatar 2022.

排除标准

  • No exclusion criteria are present except declining to provide consent for data to be used in this study.

结局指标

主要结局

Incidence and burden of Time-loss injuries

时间窗: November-December 2022

Time-loss is defined as inability of a player to complete the current or future training session or match. Injury is defined as tissue damage or other derangement of normal physical function resulting from rapid or repetitive transfer of kinetic energy.

Incidence and burden of Time-loss illnesses

时间窗: November-December 2022

Time-loss is defined as inability of a player to complete the current or future training session or match. Illness is defined as a health-related complaint or disorder experienced by an athlete, not considered as an injury.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Injury and Illness Surveillance At the FIFA World... | 临床试验